Label Changes for:

Lithium Carbonate 150 mg, 300 mg, and 600 mg capsules

October 2011

Changes have been made to the WARNINGS and ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011

 

 

WARNINGS

Unmasking of Brugada Syndrome
  • ...the unmasking of Brugada Syndrome [added]

 

PRECAUTIONS

Information for the Patients
  • ...the unmasking of Brugada Syndrome [added]

 

ADVERSE REACTIONS

Cardiovascular
  • ...the unmasking of Brugada Syndrome [added]
Hide
(web5)